Pharmacotherapy for trichotillomania

Simple item page
dc.contributor.authorHoppe L.
dc.contributor.authorIpser J.C.
dc.contributor.authorFineberg N.
dc.contributor.authorChamberlain S.
dc.contributor.authorStein D.J.
dc.date.accessioned2011-05-15T16:01:27Z
dc.date.available2011-05-15T16:01:27Z
dc.date.issued2009
dc.description.abstract[No abstract available]
dc.description.versionReview
dc.identifier.citationCochrane Database of Systematic Reviews
dc.identifier.citation3
dc.identifier.issn1469493X
dc.identifier.other10.1002/14651858.CD007662
dc.identifier.urihttp://hdl.handle.net/10019.1/11984
dc.subjectalprazolam
dc.subjectamitriptyline
dc.subjectanticonvulsive agent
dc.subjectbenzodiazepine derivative
dc.subjectbromazepam
dc.subjectcitalopram
dc.subjectclomipramine
dc.subjectclonazepam
dc.subjectdesipramine
dc.subjectescitalopram
dc.subjectetiracetam
dc.subjectfluoxetine
dc.subjectfluvoxamine
dc.subjectgabapentin
dc.subjecthaloperidol
dc.subjectimipramine
dc.subjectlamotrigine
dc.subjectmonoamine oxidase inhibitor
dc.subjectneuroleptic agent
dc.subjectolanzapine
dc.subjectparoxetine
dc.subjectquetiapine
dc.subjectrisperidone
dc.subjectserotonin noradrenalin reuptake inhibitor
dc.subjectserotonin uptake inhibitor
dc.subjectsertraline
dc.subjecttiagabine
dc.subjecttopiramate
dc.subjecttricyclic antidepressant agent
dc.subjectunindexed drug
dc.subjectcell heterogeneity
dc.subjectclinical trial
dc.subjectcognitive therapy
dc.subjectcontrolled clinical trial
dc.subjectdisease severity
dc.subjectdrug efficacy
dc.subjectdrug tolerability
dc.subjectHamilton scale
dc.subjecthuman
dc.subjectquality of life
dc.subjectrandomized controlled trial
dc.subjectrating scale
dc.subjectreview
dc.subjectsensitivity analysis
dc.subjectsensorimotor cortex
dc.subjecttreatment outcome
dc.subjecttreatment response
dc.subjecttrichotillomania
dc.titlePharmacotherapy for trichotillomania
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Publications